INTENDED USE Canine Distemper Virus Ag Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of canine Distemper virus (CDV Ag) in dog's secretions or serum. Assay Time: 5-10 min Sample: secretions or serum PRINCIPLE Canine Distemper Virus Ag Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window. The testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough Distemper antigen in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of Canine Distemper antigen in the sample.
Product Name: Coronavirus (COVID-19) Antigen Rapid Test Cassette (Swab), COVID-19 Antigen Test Kit, SARS COV 2 Variant Test Kits Sample type Throat OR nasal swab Detection type Qualitative Method: Colloidal Gold Rapid Test Function: Diagnose Certificate: ISO9001/ ISO13485/CE Format: Strip, Cassette, Midstream Sensitivity: 96.23% Specificity: 99.11% Accuracy: 98.56% Reading time: 15 minutes Packaging Details: Pouch+Box+Carton packaging (1) With our company's Logo (2) With the natural package (3) With OEM package (4) ODM
Product Name: Coronavirus (COVID-19) Antigen Rapid Test Cassette (Swab), COVID-19 Antigen Test Kit, SARS COV 2 Variant Test Kits Sample type Throat OR nasal swab Detection type Qualitative Method: Colloidal Gold Rapid Test Function: Diagnose Certificate: ISO9001/ ISO13485/CE Format: Cassette Sensitivity: 96.23% Specificity: 99.11% Accuracy: 98.56% Reading time: 15 minutes Packaging Details: Pouch+Box+Carton packaging (1) With our company's Logo (2) With the natural package (3) With OEM package (4) ODM
Various formats are available, and OEM and ODM customization is accepted.
A variety of malaria tests are available, including the Malaria Pf/Pv Test Malaria Pf/Pan Test Malaria Pf Test and Malaria Pan Test
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. EUA and CE pass shelf life: 24months since manufacturing date packing:2pcs/box,4pcs/box and so on It is for self testing and OTC, for home use, school , and any group .
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
Monkeypoxvirus (MPXV) is a double-stranded DNA virus, a member of the orthopoxvirus genus within the Poxviridae family. MPXV falls into the same genus category as Cowpox (CPX), Variola (VARV), and Vaccinia (VACV) viruses. Poxviruses cause disease in humans and many other animals; infection typically results in the formation of lesions, skin nodules or disseminated rash. MPXV causes the disease in both animals and humans. It can be transmitted through animal-to human-contact e.g., animal bites, contact with animal bodily fluids etc., human-to-human contact e.g., touching infected lesions, inhalation of respiratory droplets, and eating infected meat that has not been thoroughly cooked. The incubation period for MPXV is typically 7â??14 days, but can range from 5â??21 days. Early onset symptoms of the disease are: swollen lymph nodes, aches and pains, fever and chills, headaches, and extreme fatigue. After 1-3 days, patients develop rashes, which progress to lesions, eventually scabbing over and falling off. The disease usually lasts for around 2-4 weeks. Swollen lymph nodes are typical of monkeypox. However, lesions may be haemorrhagic or coalesce into large bullae. The Monkeypox virus Antigen Rapid Test kit is a rapid test that utilizes a combination of Monkeypox antibody coated colored particles for the detection of Monkeypox antigen in human sample.
COVID-19 Antigen Rapid Test (Saliva Lollipop) is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in Saliva samples from individuals suspected of COVID-19. Welcome to inquiry.
Boson EUA slef testing covid antigen test card, DDP Chicago airport/DDP New York airport. Any interest pls contact us!
Simens EUA self testing Antigen nasal swab test & Flowflex EUA self testing Antigen nasal swab test are availble. DDP USA. Any interest pls contact us
[Intended Usage] This kit is used for the in vitro qualitative detection of suspected cases of pneumonia caused by New Coronavirus infection, patients with suspected clusters, other patients who need to be diagnosed or differentially diagnosed with the New Coronavirus infection, and nasopharyngeal swabs, oropharyngeal swabs, and bronchoalveolar lavage fluid samples of patients with mutation beads for the New Coronavirus ORF1ab and N gene, S gene N501Y mutation and S gene E484K mutation sites. [Storage Conditions & Validity] 1. The kit should be stored frozen at -20 and protected from light; the expiration date is 6 months; the production date and expiration date are shown in the outer packaging box. 2. Avoid repeated freezing and thawing of the kit and the number of freezing and thawing shall not exceed 7 times. 3. After opening, the bottles should be stored at -20 and protected from light. The number of bottles opening times should not exceed 7 times, which will not affect the use within the validity period. [Applicable Instruments] 1. This kit has been validated on ABI7500 quantitative fluorescence PCR instrument. 2. For other models not listed, relevant experiments have not been performed or completed for this kit. If users need to use this type of instrument platform to carry out the detection of this reagent, please contact our Technical Department at for relevant support. NB: The other devices can include quantitative fluorescence PCR platforms with FAM, VIC, ROX and Cy5 channels. [Sample Requirements] 1. Nasopharyngeal swabs, oropharyngeal swabs and other methods are used to obtain samples, and it is recommended to use commercial virus sampling kits for sample collection devices. [Test Results Interpretation] 1. Negative and positive controls should be tested in each experiment and the test result can be determined only when the controls meet the quality control requirements. 2. When FAM, VIC and ROX channels are positive, Cy5 channel result may be negative due to the system competition. 3. When the internal standard result is negative, if the FAM, VIC and ROX signals of the test sample are also negative, the test result of the sample is invalid, and the cause should be found and eliminated, and the experiment repeated for this sample. [Product Performance Index] 1. Precision: The coefficient of variation Intra-batch / Inter-batch, Intra-day / Inter-day among different operators shall not be higher than 5.0%. 2. Coincidence rate of negative positive controls: The coincidence rate of positive controls and negative controls is 100%. 3. Minimum detection limit: The minimum detection limit of this kit is 500 copies/mL. [CE Mark Registration No.]: RPS/499/2021. [EC REP.]: CMC MEDICAL DEVICES & DRUGS S.L. C/ Horacio Lengo n18, C.P 29006, Milaga, Spain.
INTENDED USE For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 infection. FEATURES Coated with carefully selected specific Nucleocapsid and Spike protein antigen. Detection for IgM and IgG antibodies simultaneously. Simple operation, easy result interpreted. Rapid test within 15 minutes. RESULTS INTERPRETATION Positive: 1. The presence of 3 red lines (T1, T2 and C) within the reaction window, no matter which band appears first, indicates presence of both SARS-CoV-2 IgM and IgG antibodies. 2. The presence of 2 red lines (T1 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgM antibody. 3. The presence of 2 red lines (T2 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgG antibody. Negative: 1. The presence of line (control line) only within the reaction window indicates that no SARS-CoV-2 antibodies are detected. The results is negative. Invalid: 1. If the control(C) line is not displayed in 10-15 min, regardless of whether T1 and/or T2 line is present, the test result is invalid. It is recommended that the specimen should be re-tested. 2. The test result is invalid after 15 min. CLINICAL PERFORMANCE - Positive Percent Agreement (PPA) = 91.07% (153/168) (95% CI: 85.70%-94.92%). - Negative Percent Agreement (NPA) = 95.37% (103/108) (95% CI: 89.53%-98.48%). - Overall Rates of Agreement (ORA) = 92.75% [(153+103)/ (168+108)] (95% CI: 89.03%-95.52%). [Product Name]: SARS-CoV-2 IgM/IgG Duo Test [Product Code]: Cat# FP-319 [Sample Type]: Whole blood /Plasma/Serum [Sample Volume]: 20L /10L/10L [Detection Method]: Colloidal Gold [Reaction Time]: 10-15min [Packing Size]: 1T x 20 cassettes per box + Sample diluent 1 vial x 5mL. [Storage Condition]: 2oC ~ 30oC [Shelf Life]: 12 months [CE Mark Registration No.]: RPS/499/2021.
Our covid-19 antigen saliva test and covid 19 ag swab test already got Germany BFARM number and passed PEI test, and antigen nasal test has been registered on EU common list, hope to cooerate with your esteemed company, self testing is on progress. Hope to cooperate with your esteemed company, and we got very good feedback from many clients, promise you high quality.
20 tests/box
covid antigen nasal rapid test passed the Germany PEI testing and registered on EU Common List
20 tests/box, 1 pcs/box, 5pcs/box
Covid Ab IgG/IgM Ab Whole blood test device Covid Antigen Ag swab rapid test card Covid Antigen Ag saliva rapid test card
When the epidemic is waiting for an opportunity again, to quickly control the spread of the virus, nucleic acid testing has become the only way to go, and it has also attracted attention from all walks of life. However, there are many factors that affect the results of nucleic acid testing, including sample collection location, collection method, storage and transportation process, nucleic acid extraction operation, and so on. Among them, the stability of the sample is a key link. How to quickly inactivate the virus and protect the viral nucleic acid from being degraded, maintaining the stability of the virus sample storage solution has become a top priority. Step 1: Break the shell and eliminate the "combat power" Like other RNA viruses, the results of the new coronavirus are simply composed of a protein shell wrapped in single-stranded nucleic acid-RNA. We can simply think of the RNA of the virus as the "brain" that gives orders, and the protein is the "limbs" that execute orders. The new coronavirus infects the human body and reproduces and causes symptoms. This process is mainly completed by the biologically active protein structure outside the virus. The inactivated virus preservation solution is mainly the virus modified by the nucleic acid extraction lysis solution; it is a powerful protein denaturant that can quickly dissolve the protein and cause the virus structure to be broken. When the clinical sample with the new coronavirus is mixed with the preservation solution, the virus in the sample is affected by the lysis solution, and the protein shell is quickly destroyed, and this damage is irreversible. At this time, the virus has lost its evil "minions" and no longer has the ability to infect people, thus ensuring the safety of contacts during sample transportation and processing. Step 2: Inhibit enzyme activity and escort the "ID card" After the shell is lysed, the RNA of the new coronavirus is free in the preservation solution. As a single-stranded macromolecule, the stability of RNA is not as immobile as double-stranded DNA. The RNase that exists everywhere in the natural environment is the culprit that causes RNA to hydrolyze and break. Therefore, it is generally considered that the viral RNA that has lost its outer shell protection is In addition to the inactivated virus storage solution, the virus preservation solution produced by Desheng also has a non-inactivated virus storage solution. It retains the protein coat of the virus and the viral nucleic acid DNA or RNA at the same time, so that the virus has the integrity of the protein epitope and nucleic acid in vitro. Of course, there is a certain risk of infectivity when operating errors. Long-term storage after sampling needs to keep strictly low temperature. Regardless of the virus preservation solution, we need to strictly operate, store or transport in accordance with the requirements when using it.